EU drug watchdog warns on use of Sanofi antibiotic
LONDON, March 30 (Reuters) - The European Medicines Agency said on Friday it was recommending restricted use and strengthened warnings for Sanofi-Aventis SA's (SASY.PA) antibiotic Ketek.
The move follows similar restrictions announced by U.S. regulators last month.
Europe's drugs watchdog said the drug should not be used for treating bronchitis, sinusitis and tonsillitis unless infections were caused by bacterial strains resistant to other antibiotics.
Ketek remains suitable, however, for the treatment of community-acquired pneumonia without such restrictions, the London-based agency said.
((Reporting by Ben Hirschler; email: ben.hirschler@reuters.com; Reuters Messaging: ben.hirschler.reuters.com@reuters.net; +44 20 7542 5082)) Keywords: SANOFI KETEK/
(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nL30570960










